Literature DB >> 29047148

Epidemiological survey of patients with psoriasis in Matsumoto city, Nagano Prefecture, Japan.

Eisaku Ogawa1, Ryuhei Okuyama1, Tomoko Seki1, Aya Kobayashi1, Naoki Oiso2, Masahiko Muto3, Hidemi Nakagawa4, Akira Kawada2.   

Abstract

A local epidemiological survey of psoriasis was conducted from 19 February to 30 June 2016 in Matsumoto city, Nagano Prefecture, Japan. Patients were predominantly male (268 cases, 71.5% males vs 107 cases, 28.5% females). We estimated that the prevalence of psoriasis was 0.097% in the Matsumoto area. The clinical types of psoriasis identified were psoriasis vulgaris (90.7%), psoriatic arthritis (5.9%), pustular psoriasis (2.1%), guttate psoriasis (1.0%) and psoriatic erythroderma (0.3%). The topical therapeutic agents included corticosteroids (84.0%), vitamin D3 analogs (61.5%), and a combination of calcipotriol and betamethasone dipropionate (31.0%). Current systemic treatments included cyclosporin (9.0%), etretinate (7.4%) and methotrexate (1.3%). Biologic treatments included adalimumab (4.0%), ustekinumab (2.7%), infliximab (1.3%) and secukinumab (0.8%). Ultraviolet B therapy (11.3%) was the predominant phototherapy in which narrow band ultraviolet B therapy accounted for the majority, followed by psoralen and ultraviolet A therapy (1.0%). According to the recent evolution of psoriasis treatment, the use of biologics has been increasing. This study demonstrates the changes of treatment trends of psoriasis in a non-metropolitan regional area.
© 2017 Japanese Dermatological Association.

Entities:  

Keywords:  Japan; epidemiology; examination; psoriasis; therapeutics

Mesh:

Substances:

Year:  2017        PMID: 29047148     DOI: 10.1111/1346-8138.14101

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

Review 1.  Dermatology: how to manage psoriasis and recognize differences in pathophysiology and presentation in patients with skin of colour.

Authors:  Yuliya Lytvyn; Muskaan Sachdeva; Asfandyar Mufti; Jensen Yeung
Journal:  Drugs Context       Date:  2022-05-31

Review 2.  The contribution of IL-17 to the development of autoimmunity in psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Innate Immun       Date:  2019-05-24       Impact factor: 2.680

Review 3.  Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.

Authors:  Masutaka Furue; Akiko Hashimoto-Hachiya; Gaku Tsuji
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

4.  Microbiota differences of skin and pharyngeal microbiota between patients with plaque and guttate psoriasis in China.

Authors:  Jingjin Hu; Wenhua Lu; Xingyu Li; Jing Yang; Minjia Tan; Kun Hu; Qiaolin Wang; Sichun Deng; Yijie Liu; Junchen Chen; Wu Zhu; Yehong Kuang
Journal:  Front Microbiol       Date:  2022-08-10       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.